Mackenzie Financial Corp boosted its holdings in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 1.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,708,975 shares of the company's stock after buying an additional 17,151 shares during the quarter. Mackenzie Financial Corp owned 0.07% of Procter & Gamble worth $286,510,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the business. Forum Financial Management LP raised its position in Procter & Gamble by 12.6% during the 4th quarter. Forum Financial Management LP now owns 24,234 shares of the company's stock worth $4,063,000 after buying an additional 2,720 shares during the last quarter. Griffith & Werner Inc. acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $3,527,000. Wealth Management Strategies Inc. acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $273,000. Sunbeam Capital Management LLC purchased a new stake in Procter & Gamble during the fourth quarter worth $34,000. Finally, Michels Family Financial LLC acquired a new stake in Procter & Gamble during the fourth quarter valued at $359,000. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
PG traded up $1.89 on Tuesday, hitting $167.75. 11,416,704 shares of the company's stock were exchanged, compared to its average volume of 7,291,845. The Procter & Gamble Company has a fifty-two week low of $156.58 and a fifty-two week high of $180.43. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The firm has a 50-day moving average price of $164.13 and a 200-day moving average price of $167.34. The stock has a market cap of $393.30 billion, a price-to-earnings ratio of 26.71, a P/E/G ratio of 3.76 and a beta of 0.41.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.53 by $0.01. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The company had revenue of $19.78 billion for the quarter, compared to analysts' expectations of $20.42 billion. During the same quarter in the previous year, the company posted $1.52 EPS. The firm's quarterly revenue was down 2.1% on a year-over-year basis. As a group, equities analysts anticipate that The Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Monday, April 21st were paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.52%. The ex-dividend date of this dividend was Monday, April 21st. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. Procter & Gamble's payout ratio is 66.98%.
Analysts Set New Price Targets
PG has been the topic of several recent analyst reports. JPMorgan Chase & Co. lowered their target price on shares of Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Redburn Atlantic cut Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price target for the company. in a report on Thursday, May 1st. Redburn Partners set a $161.00 price target on Procter & Gamble in a research report on Thursday, May 1st. Truist Financial lowered their price target on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Finally, Barclays reiterated an "equal weight" rating on shares of Procter & Gamble in a research report on Thursday, March 27th. Eight equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $178.52.
View Our Latest Report on Procter & Gamble
Insiders Place Their Bets
In other news, CEO Jennifer L. Davis sold 1,000 shares of the business's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total transaction of $161,380.00. Following the transaction, the chief executive officer now owns 51,965 shares of the company's stock, valued at approximately $8,386,111.70. The trade was a 1.89% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Gary A. Coombe sold 35,000 shares of the business's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the transaction, the chief executive officer now directly owns 22,051 shares in the company, valued at approximately $3,829,817.68. The trade was a 61.35% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 46,520 shares of company stock valued at $7,909,388 in the last 90 days. 0.18% of the stock is owned by insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report